Free Trial

GoodRx (GDRX) Competitors

GoodRx logo
$5.05 +0.09 (+1.81%)
Closing price 04:00 PM Eastern
Extended Trading
$5.08 +0.03 (+0.50%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GDRX vs. LYFT, ETSY, AMTM, MARA, WSC, SEZL, LIF, QBTS, FTDR, and STNE

Should you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include Lyft (LYFT), Etsy (ETSY), Amentum (AMTM), Marathon Digital (MARA), WillScot (WSC), Sezzle (SEZL), Life360 (LIF), D-Wave Quantum (QBTS), Frontdoor (FTDR), and StoneCo (STNE). These companies are all part of the "business services" industry.

GoodRx vs. Its Competitors

GoodRx (NASDAQ:GDRX) and Lyft (NASDAQ:LYFT) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

Lyft has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than Lyft, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoodRx$792.32M2.28$16.39M$0.0863.13
Lyft$5.79B1.13$22.78M$0.15104.73

GoodRx has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Lyft has a beta of 2.2, indicating that its stock price is 120% more volatile than the S&P 500.

GoodRx currently has a consensus price target of $6.55, suggesting a potential upside of 29.61%. Lyft has a consensus price target of $16.64, suggesting a potential upside of 5.91%. Given GoodRx's stronger consensus rating and higher probable upside, analysts plainly believe GoodRx is more favorable than Lyft.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.64
Lyft
1 Sell rating(s)
25 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.23

In the previous week, Lyft had 31 more articles in the media than GoodRx. MarketBeat recorded 32 mentions for Lyft and 1 mentions for GoodRx. GoodRx's average media sentiment score of 0.93 beat Lyft's score of 0.31 indicating that GoodRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GoodRx
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Lyft
6 Very Positive mention(s)
8 Positive mention(s)
10 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Neutral

63.8% of GoodRx shares are held by institutional investors. Comparatively, 83.1% of Lyft shares are held by institutional investors. 4.5% of GoodRx shares are held by insiders. Comparatively, 3.1% of Lyft shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

GoodRx has a net margin of 3.57% compared to Lyft's net margin of 0.95%. Lyft's return on equity of 11.28% beat GoodRx's return on equity.

Company Net Margins Return on Equity Return on Assets
GoodRx3.57% 7.85% 3.91%
Lyft 0.95%11.28%1.50%

Summary

Lyft beats GoodRx on 9 of the 17 factors compared between the two stocks.

Get GoodRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GDRX vs. The Competition

MetricGoodRxMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.77B$7.46B$5.54B$8.87B
Dividend YieldN/A2.77%5.39%4.10%
P/E Ratio63.1328.1026.1719.90
Price / Sales2.2832.01414.67113.66
Price / Cash15.5921.4136.1356.90
Price / Book2.676.628.055.38
Net Income$16.39M$230.16M$3.15B$248.50M
7 Day Performance2.85%3.57%1.85%2.97%
1 Month Performance32.20%5.73%4.81%6.02%
1 Year Performance-35.42%33.35%34.86%20.39%

GoodRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GDRX
GoodRx
3.0513 of 5 stars
$5.05
+1.8%
$6.55
+29.6%
-36.6%$1.77B$792.32M63.13950
LYFT
Lyft
3.8798 of 5 stars
$14.95
+2.9%
$16.40
+9.7%
+15.9%$6.25B$5.96B99.672,934Trending News
ETSY
Etsy
3.6468 of 5 stars
$53.92
-4.0%
$49.87
-7.5%
-9.9%$5.62B$2.81B38.512,400Analyst Forecast
AMTM
Amentum
2.2776 of 5 stars
$21.94
+0.5%
$25.22
+15.0%
N/A$5.34B$8.39B0.0053,000
MARA
Marathon Digital
1.8582 of 5 stars
$14.18
-1.0%
$20.94
+47.7%
-30.4%$4.99B$656.38M-9.789Options Volume
WSC
WillScot
4.3476 of 5 stars
$26.72
+1.9%
$40.63
+52.0%
-23.9%$4.87B$2.40B296.924,500
SEZL
Sezzle
2.2463 of 5 stars
$144.98
-1.4%
$96.94
-33.1%
+1,030.4%$4.83B$271.13M48.98540Analyst Forecast
Insider Trade
LIF
Life360
1.5049 of 5 stars
$61.78
-0.3%
$58.67
-5.0%
+102.9%$4.73B$371.48M686.44600Analyst Forecast
Insider Trade
QBTS
D-Wave Quantum
1.5086 of 5 stars
$14.92
-4.7%
$13.57
-9.0%
+1,275.9%$4.36B$8.83M-24.873Trending News
Analyst Forecast
Gap Up
FTDR
Frontdoor
3.1996 of 5 stars
$59.03
+0.8%
$54.00
-8.5%
+76.5%$4.34B$1.89B19.102,120Positive News
STNE
StoneCo
3.4663 of 5 stars
$14.96
+3.0%
$15.63
+4.4%
+37.6%$4.28B$13.27B-19.1816,793

Related Companies and Tools


This page (NASDAQ:GDRX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners